Name:

Email Address:

Address, City, State, Zip:

Main / Home Phone:

Second Phone Number:

Comments:

Diagnosis:

Mesothelioma Asbestosis Lung Cancer Other No Diagnosis

Purpose: The purpose of this trial is to:

• Assess whether drug can hinder division, growth or lifespan of cancer cells
• Assess effectiveness of treatment on patients
• Monitor any side effects from use of treatment

Eligibility: To be eligible to join this clinical trial you must:

• Be at least 13 years old if you have osteosarcoma, or 18 years old in any other circumstances
• Have a measurable disease
• Not have had chemotherapy for at least six weeks
• Not have had radiation therapy to the brain for at least four weeks
• Not have had surgery for at least four weeks

Treatment: The process will entail:

• A five day continuous infusion of the drug every three weeks (up to nine courses)
• Evaluation at four weeks

Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.